Total VITAS admissions increased 9.0% in the second quarter of 2026 compared to the second quarter of 2025. In the second quarter of 2026, VITAS accrued $500,000 in Medicare Cap billing limitation.

Chemed expects full-year earnings in the range of $25 to $25.75 per share. This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CH ...

Chemed (CHE) delivered earnings and revenue surprises of +9.19% and +1.86%, respectively, for the quarter ended June 2026. Do ...

Navitas expects to substantially exit the mobile and the low-end consumer market by the end of this year, the management said ...

Healthcare services company Chemed Corporation (NYSE:CHE) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, ...

Chemed crushed second-quarter earnings with a $6.06 EPS beat as VITAS hospice revenue jumped 11.9% on a dramatic shrink in Medicare Cap charges to $0.5 million from $16.4 million year ago, ...

The company's second-quarter performance raised investor concerns.

Explore Chemed healthcare and plumbing operations, hospice services and nationwide business activities within the Russell ...

MIRAMAR, Fla., July 2, 2026 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of hospice and palliative care, today announced the promotion of Bryan Wysong to chief operations officer ...

The investment will support construction and expansion projects at Warrigal Mt Terry, Uniting Farmborough, Hillside at ...

Live Updates Stay On This Site to Receive Live $NVTS Q2 Earnings Updates Pinned Just now Live This live blog is being updated ...

Total revenue grew 22% sequentially with high-power markets growing more than 50% year-over-year and driving expanded gross ...